C. Difficile Testing Protocol
|
|
- Frederica Hill
- 6 years ago
- Views:
Transcription
1 C. Difficile Testing Protocol Caroline Donovan, RN, BSN, ONC- Infection Control Practitioner Abegail Pangan, RN, MSN, CIC- Infection Control Practitioner U.S. NEWS & WORLD REPORT RANKINGS Acute Care Hospital (Orthopedic Specialty Hospital) New York City 215 Beds 40 Operating Rooms 30,000 Procedures 352 Physicians
2 What makes HSS Different? Orthopedic specialty hospital 30,000 procedures annually Hip replacements (HPRO) & Knee replacements (KPRO) Only NHSN Reportable procedures 12,000 13,000 HPRO & KPRO procedures annually 2 C. Diff Prevention
3 Clostridium Difficile Effects Patient Outcomes 3
4 Clostridium Difficile Testing Acceptable Specimen Loose or watery stool specimen Suspected ileus caused by infection: verbal communication with lab occurs prior to submission of sample Rejection Criteria Specimens that are not liquid or soft Specimens from infants under 1 year old should be discouraged Specimen received greater than 24 hours after collection Rectal swab specimens Test for cure or testing from asymptomatic individuals 4
5 Clostridium Difficile Laboratory Testing Stool Culture for toxin-producing C. diff (*Gold Standard) Most accurate, but has slow turn around of up to 3 days; not clinically feasible Nucleic Acid Amplified Tests (NAAT) including Polymerase Chain Reaction (PCR) High sensitivity and high specificity May lead to false positive results and increase detection of colonizers Enzyme Immunoassay (EIA) Rapid results, high specificity, but low sensitivity Glutamate Dehydrogenase (GDH) GDH is an enzyme produced in large amounts with toxins A and B High sensitivity, but low specificity 5
6 NHSN C. difficile Lab ID Event CDI-positive laboratory assay: All non duplicate positive laboratory test result for C. diff toxin A and/or B, (includes molecular and toxin assays) tested on an unformed stool specimen 6
7 Problem 7
8 Antimicrobial Stewardship 8
9 The C.difficile algorithm was created to help guide clinicians in the proper ordering of C. difficile testing. It is located in the C. difficile hospital policy. 9
10 What Our EMR Implementation Allowed Us To Do Infection Preventionist In House Staff Isolation / Infection Mismatch report Laboratory based alert system that identifies and flag infection status Automatic Contact isolation order is entered when test is ordered Infection Control Line listing of positive test in a time period Alert if C. diff test is ordered which allows early identification if appropriate C. diff testing is performed Best Practice Advisory House census list- identifies isolation/ infection status Positive test auto flagged in the patient s infection banner Nurse will see the contact isolation order once C. diff test is enteredpreemptive isolation Allows communication of any increased trend of cases in a unit Nurses avoid specimen collection if testing is inappropriate End user is informed of the C. diff testing algorithm 10
11 Process and Governance 11
12 EPIC replicated the algorithm in the form of a Best Practice Advisory (BPA) for prescribers to review when ordering testing. 12
13 Selecting All Questions Reviewed is required in order to select the Accept button. 13
14 Once accepted, both Clostridium Difficile Toxin and Contact Isolation Status display in the New Orders to be signed list. If a patient is already on Contact Precautions, only testing will populate. 14
15 When the test is ordered, Infection Control Practitioners are alerted in the Isolation and Infection Census by the automatic Contact Isolation order and an alert seen in the C.diff Order column. Staff members are able view the Isolation status on the EPIC banner. 15 Staff members now see both Isolation and Infection on the EPIC banner. The Infection Control Practitioners or Microbiology department adds the infection type once the test is positive in the infection tab to clarify for staff members why the patient is on Contact Isolation.
16 C.difficile Tests Received by Microbiology Lab Go Live for Algorithm: 03/16/17 15 Tests
17 Test Sent and Positive Results Go Live for Algorithm: 03/16/ Tests Positive Hospital onset
18 Better Patient Outcomes Decreased unnecessary testing and treatment Early identification and prompt Contact Isolation Increased communication of patient infection status to in house staff Improved active surveillance and reporting Utilization of Antibiotic Stewardship 18
DUKE ANTIMICROBIAL STEWARDSHIP OUTREACH NETWORK (DASON) Antimicrobial Stewardship News. Volume 3, Number 6, June 2015
DUKE ANTIMICROBIAL STEWARDSHIP OUTREACH NETWORK (DASON) Antimicrobial Stewardship News Volume 3, Number 6, June 2015 Diagnostic Testing for Clostridium difficile Infection Background Clostridium difficile
More information6/14/2012. Welcome! PRESENTATION OUTLINE CLOSTRIDIUM DIFFICILE PREVENTION. Teaming Up to Prevent Infections! 1) Impact. 2) Testing Recommendations
CLOSTRIDIUM DIFFICILE PREVENTION Beth Goodall, RN, BSN Board Certified in Infection Prevention and Control DCH Health System Epidemiology Director Welcome! Teaming Up to Prevent Infections! CLOSTRIDIUM
More informationLoyola s C diff Journey
Loyola s C diff Journey Kevin Smith, MD Associate Chief Medical Officer, Quality & Safety Aziz Ansari, DO Associate Chief Medical Officer, Clinical Optimization/Revenue Integrity Background Loyola Medicine
More informationClostridium difficile Infection (CDI) Management Guideline
Clostridium difficile Infection (CDI) Management Guideline Do not test all patients with loose or watery stools for CDI o CDI is responsible for
More informationQuestions and answers about the laboratory diagnosis of Clostridium difficile infection (CDI)
Questions and answers about the laboratory diagnosis of Clostridium difficile infection (CDI) The NHS Centre for Evidence based Purchasing (CEP) has published the results of an evaluation of the performance
More informationClostridium difficile Diagnostic and Clinical Challenges
Papers in Press. Published December 11, 2015 as doi:10.1373/clinchem.2015.243717 The latest version is at http://hwmaint.clinchem.org/cgi/doi/10.1373/clinchem.2015.243717 Clinical Chemistry 62:2 000 000
More informationJourney to Decreasing Clostridium Difficile and the Unexpected Twist. Jackie Morton, Infection Prevention Cortney Swiggart, Medication Safety Officer
Journey to Decreasing Clostridium Difficile and the Unexpected Twist Jackie Morton, Infection Prevention Cortney Swiggart, Medication Safety Officer 4/13/2018 Objectives Discuss the organism and clinical
More informationClostridium difficile Infection (CDI) Guideline Update:
Clostridium difficile Infection (CDI) Guideline Update: Understanding the Data Behind the Recommendations Erik R. Dubberke, MD, MSPH A Webinar for HealthTrust Members Professor of Medicine September 24,
More informationClostridium difficile infection surveillance: Applying the case definition
Clostridium difficile infection surveillance: Applying the case definition PICNet Conference March 3 rd 2016 Presented by: Tara Leigh Donovan, MSc Managing Consultant (Former Epidemiologist) 1 Disclaimer
More informationOriginal Article. Infection Control & Hospital Epidemiology (2019), 1 5 doi: /ice
Infection Control & Hospital Epidemiology (2019), 1 5 doi:10.1017/ice.2018.347 Original Article Healthcare provider diagnostic testing practices for identification of Clostridioides (Clostridium) difficile
More informationEDUCATIONAL COMMENTARY CLOSTRIDIUM DIFFICILE UPDATE
EDUCATIONAL COMMENTARY CLOSTRIDIUM DIFFICILE UPDATE Educational commentary is provided through our affiliation with the American Society for Clinical Pathology (ASCP). To obtain FREE CME/CMLE credits click
More informationClostridium Difficile Infection: Applying New Treatment Guidelines and Strategies to Reduce Recurrence Rate
Clostridium Difficile Infection: Applying New Treatment Guidelines and Strategies to Reduce Recurrence Rate Objectives Summarize the changing epidemiology and demographics of patients at risk for Clostridium
More informationDiagnosis, Management, and Prevention of Clostridium difficile infection in Long-Term Care Facilities: A Review
Diagnosis, Management, and Prevention of Clostridium difficile infection in Long-Term Care Facilities: A Review October 18, 2010 James Kahn and Carolyn Kenney, MSIV Overview Burden of disease associated
More informationClostridium difficile Infection: Diagnosis and Management
Clostridium difficile Infection: Diagnosis and Management Brian Viviano D.O. Case study 42 year old female with history of essential hypertension and COPD presents to ED complaining of 24 hours of intractable,
More informationClostridium difficile: An Overview
Clostridium difficile: An Overview CDI Webinar July 11, 2017 PUBLIC HEALTH DIVISION Acute and Communicable Disease Prevention Section Outline Background Microbiology Burden Pathogenesis Diagnostic testing
More informationL. Clifford McDonald, MD. Senior Advisor for Science and Integrity September 16, 2015
Controversies and Current Issues in Diagnosis, Surveillance, and Treatment of Clostridium difficile infeciton L. Clifford McDonald, MD Senior Advisor for Science and Integrity September 16, 2015 Division
More informationUnderstanding C. diff. atomalliance.org/cdifftraining
Understanding C. diff atomalliance.org/cdifftraining This booklet is a printed guide of the online educational resource atomalliance.org/cdifftraining Target Audience Understanding C. diff This educational
More informationThe Bristol Stool Scale and Its Relationship to Clostridium difficile Infection
JCM Accepts, published online ahead of print on 16 July 2014 J. Clin. Microbiol. doi:10.1128/jcm.01303-14 Copyright 2014, American Society for Microbiology. All Rights Reserved. 1 The Bristol Stool Scale
More informationECHO-Antibiotic Stewardship Program
ECHO-Antibiotic Stewardship Program More Interesting Recent Literature Updates April 20, 2017 Charles Krasner, M.D. University of NV, Reno School of Medicine Sierra NV Veterans Affairs Medical Center Antibiotic
More informationDISCLAIMER: ECHO Nevada emphasizes patient privacy and asks participants to not share ANY Protected Health Information during ECHO clinics.
DISCLAIMER: Video will be taken at this clinic and potentially used in Project ECHO promotional materials. By attending this clinic, you consent to have your photo taken and allow Project ECHO to use this
More informationMarch 3, To: Hospitals, Long Term Care Facilities, and Local Health Departments
March 3, 2010 To: Hospitals, Long Term Care Facilities, and Local Health Departments From: NYSDOH Bureau of Healthcare Associated Infections HEALTH ADVISORY: GUIDANCE FOR PREVENTION AND CONTROL OF HEALTHCARE
More informationClostridium difficile infection (CDI) Week 52 (Ending 30/12/2017)
Clostridium difficile infection (CDI) Week 52 (Ending 30/12/2017) What is Clostridium difficile? Clostridium difficile is a Gram-positive anaerobic spore forming bacillus. It is ubiquitous in nature and
More informationCase 1. Which of the following would be next appropriate investigation/s regarding the pts diarrhoea?
Case 1 21 yr old HIV +ve, Cd4-100 HAART naïve Profuse diarrhoea for 3/52. Stool MC&S ve Which of the following would be next appropriate investigation/s regarding the pts diarrhoea? Repeat stool MC&S Stool
More informationACG Clinical Guideline: Diagnosis, Treatment, and Prevention of Clostridium difficile Infections
ACG Clinical Guideline: Diagnosis, Treatment, and Prevention of Clostridium difficile Infections Christina M. Surawicz, MD 1, Lawrence J. Brandt, MD 2, David G. Binion, MD 3, Ashwin N. Ananthakrishnan,
More informationDETECTION OF TOXIGENIC CLOSTRIDIUM DIFFICILE
CLINICAL GUIDELINES For use with the UnitedHealthcare Laboratory Benefit Management Program, administered by BeaconLBS DETECTION OF TOXIGENIC CLOSTRIDIUM DIFFICILE Policy Number: PDS 021 Effective Date:
More informationTITLE OF PRESENTATION
TITLE OF PRESENTATION Can C. Subtitle difficile of Infection Presentation Rates Be Used to Judge Prevention Success for Hospitals? David P. Calfee, MD, MS Associate Professor of Medicine and Public Health
More informationStony Brook Adult Clostridium difficile Management Guidelines. Discontinue all unnecessary antibiotics
Stony Brook Adult Clostridium difficile Management Guidelines Summary: Use of the C Diff Infection (CDI) PowerPlan (Adult) Required Patient with clinical findings suggestive of Clostridium difficile infection
More informationClostridium Difficile colitismore
Clostridium Difficile colitismore virulent than ever ECHO- February 18, 2016 Charles Krasner, M.D. UNR School of Medicine Sierra NV Veterans Affairs Hospital Growing problem of pseudomembranous colitis
More informationA Pharmacist Perspective
Leveraging Technology to Reduce CDI A Pharmacist Perspective Ed Eiland, Pharm.D., MBA, BCPS (AQ-ID) Clinical Practice and Business Supervisor Huntsville Hospital System Huntsville Hospital 881 licensed
More information9/18/2018. Clostridium Difficile: Updates on Diagnosis and Treatment. Clostridium difficile Infection (CDI) Clostridium difficile Infection (CDI)
Clostridium Difficile: Updates on Diagnosis and Treatment Elizabeth Hudson, DO, MPH 9/25/18 Antibiotic-associated diarrhea and colitis were well established soon after widespread use of antibiotics In
More informationHRET HIIN Diagnostic Error Virtual Event
HRET HIIN Diagnostic Error Virtual Event Promoting Diagnostic Stewardship: Effectively Reducing Diagnostic Errors September 19, 2017 1 Jordan Steiger, MPH Program Manager, HRET WELCOME AND INTRODUCTIONS
More informationC. DIFF QUIK CHEK COMPLETE. Get the complete diagnostic picture with just one test. TAP HERE TO SEE THE NEXT PAGE
C. DIFF QUIK CHEK COMPLETE Get the complete diagnostic picture with just one test. TAP HERE TO SEE THE PAGE CLINICIAN Would actionable C. difficile test results in less than 30 minutes improve patient
More informationModern approach to Clostridium Difficile Infection
Modern approach to Clostridium Difficile Infection Pseudomembranous Colitis: Principles for diagnosis and treatment Aggelos Stefos Internist, Infectious diseases Specialist Department of Medicine and Research
More informationAPIC NHSN Webinar. May 16, National Center for Emerging and Zoonotic Infectious Diseases
National Center for Emerging and Zoonotic Infectious Diseases APIC NHSN Webinar May 16, 2018 Denise Leaptrot Lindsey Weiner LaTasha Powell Dominique Godfrey Disclosures The following speakers discloses
More informationAnnex C: - CDI What s the diff? 4 th Annual Outbreak Management Workshop September 19, 2013 Naideen Bailey & Grace Volkening
Annex C: - CDI What s the diff? 4 th Annual Outbreak Management Workshop September 19, 2013 Naideen Bailey & Grace Volkening There s an updated Annex C Annex C is an extension to the PIDAC Infection Prevention
More informationAdvances in Gastrointestinal Pathogen Detection
Advances in Gastrointestinal Pathogen Detection Erin McElvania TeKippe, Ph.D., D(ABMM) Director of Clinical Microbiology Children s Health System, Assistant Professor of Pathology and Pediatrics UT Southwestern
More informationReducing Readmissions and Improving Outcomes at OhioHealth Mansfield Hospital:
Reducing Readmissions and Improving Outcomes at OhioHealth Mansfield Hospital: Eugenio H. Zabaleta, Ph.D. Clinical Chemist OhioHealth Mansfield Hospital Reducing Readmissions and Improving Outcomes at
More informationRound Robin Highlights of Infection Control Practices
Round Robin Highlights of Infection Control Practices Arkansas Department of Health Healthcare-Associated Infections Program Staff To Isolate or Not To Isolate: That Is The Question Kelley Garner, MPH,
More informationIP Lab Webinar 8/23/2012
2 What Infection Preventionists need to know about the Laboratory Anne Maher, MS, M(ASCP), CIC Richard VanEnk PhD, CIC 1 Objectives Describe what the laboratory can do for you; common laboratory tests
More informationNucleic Acid Amplification Test for Tuberculosis. Heidi Behm, RN, MPH Acting TB Controller HIV/STD/TB Program Oregon, Department of Health Services
Nucleic Acid Amplification Test for Tuberculosis Heidi Behm, RN, MPH Acting TB Controller HIV/STD/TB Program Oregon, Department of Health Services What is this test? Nucleic Acid Amplification Test (NAAT)
More informationC Difficile - The Ultimate Challenge: Controlling the Spread
C Difficile - The Ultimate Challenge: Controlling the Spread Linda R. Greene, RN, MPS, CIC Manager of Infection Prevention Highland Hospital Rochester, NY University of Rochester Medical Center linda_greene@urmc.rochester.edu
More informationAn APIC Guide 2008 Guide to the Elimination of Clostridium difficile in Healthcare Settings
An APIC Guide 2008 Guide to the Elimination of Clostridium difficile in Healthcare Settings About APIC APIC s mission is to improve health and patient safety by reducing risks of infection and other adverse
More informationClostridium difficile
Clostridium difficile Care Homes IPC Study Day Sue Barber Infection Prevention & Control Lead AV & Chiltern CCG s Clostridium difficile A spore forming Bacterium. Difficult to grow in the laboratory hence
More informationENGLISH FOR PROFESSIONAL PURPOSES UNIT 3 HOW TO DEAL WITH CLOSTRIDIUM DIFFICILE
ENGLISH FOR PROFESSIONAL PURPOSES UNIT 3 HOW TO DEAL WITH CLOSTRIDIUM DIFFICILE The diagnosis of CDI should be based on a combination of clinical and laboratory findings. A case definition for the usual
More informationLos Angeles County Department of Public Health: Your Partner in CDI Prevention
Los Angeles County Department of Public Health: Your Partner in CDI Prevention Dawn Terashita, MD, MPH Acute Communicable Disease Control Los Angeles County Department of Public Health dterashita@ph.lacounty.gov
More informationInfection Prevention & Control Core Skills Level 2
Infection Prevention & Control Core Skills Level 2 Learning outcomes Risk assessment of patients Critical examination of the situation MRSA, CDT & CPE Ongoing challenges future-proofing infection control
More informationNew Molecular Diagnostic Assays for Solana Performance Assessment, Workflow Analysis, and Clinical Utility
New Molecular Diagnostic Assays for Solana Performance Assessment, Workflow Analysis, and Clinical Utility Gerald A. Capraro, Ph.D., D(ABMM) Director, Clinical Microbiology Carolinas Pathology Group Atrium
More informationInfection Control: Meeting the Challenge
22nd Annual Midas+ User Symposium June 2 5, 2013 Tucson, Arizona Infection Control: Meeting the Challenge Wednesday, June 5, 2:30 pm The data demands placed on Infection Control departments have significantly
More informationHistorical Perspective
The Diagnosis of C. difficile Infections: Does Molecular Make it More or Less difficile? Stephen M. Brecher Ph.D. VA Boston Health Care System BU School of Medicine The opinions expressed in this presentation
More informationObjectives Clostridium difficile Infections, So Many Tests, Which One to Choose?
Objectives Clostridium difficile Infections, So Many Tests, Which One to Choose? March 9, 0 http://www.slh.wisc.edu/outreach-data/event-detail.php?id=03 Raymond P. Podzorski, Ph.D., D(ABMM) Clinical Microbiologist
More informationProtocol for the Scottish Surveillance Programme for Clostridium difficile infection.
National Services Scotland Protocol for the Scottish Surveillance Programme for Clostridium difficile infection. User manual. Version 4.0 Revised January 2017 Health Protection Scotland is a division of
More informationClinical. Clostridium Difficile: Standard Operating Procedure. Document Control Summary. Contents
Clinical Clostridium Difficile: Standard Operating Procedure Document Control Summary Status: Version: Author/Title: Owner/Title: Approved by: Ratified: Related Trust Strategy and/or Strategic Aims Implementation
More informationProcedure for the Prevention Control and Management of Clostridium difficile Infection in Care Settings in Shetland
Procedure for the Prevention Control and Management of Clostridium difficile Infection in Care Settings in Shetland Adapted from: Model Infection Control Policies (Transmission Based), HPS ICT September
More informationTest Bulletin. Save time, money, resources, and precious blood by NOT collecting extra specimens just in case
Test Bulletin October 2018 Save time, money, resources, and precious blood by NOT collecting extra specimens just in case ACL Laboratories has seen an increase in the number of specimens submitted without
More informationUpdates to pharmacological management in the prevention of recurrent Clostridium difficile
Updates to pharmacological management in the prevention of recurrent Clostridium difficile Julia Shlensky, PharmD PGY2 Internal Medicine Resident September 12, 2017 2017 MFMER slide-1 Clinical Impact Increasing
More informationThe objectives of this presentation are; to increase awareness of the issue of antimicrobial resistant gonorrhea, and to inform primary care and
1 Antimicrobial resistant gonorrhea is an emerging public health threat that needs to be addressed. Neisseria gonorrhoeae is able to develop resistance to antimicrobials quickly. Effective antibiotic stewardship
More informationJMSCR Vol 05 Issue 07 Page July 2017
www.jmscr.igmpublication.org Impact Factor 5.84 Index Copernicus Value: 83.27 ISSN (e)-2347-176x ISSN (p) 2455-0450 DOI: https://dx.doi.org/10.18535/jmscr/v5i7.15 Rapid Diagnosis of Toxigenic Clostridium
More informationIndicator Definition
Hospital Acquired Clostridium difficile Infection (CDI) Rate Full data definition sign-off completed. Name of Measure Name of Measure (short) Domain Type of Measure Business Context Rationale Hospital
More informationChain of Infection Agent Mode of transmission Contact (direct, indirect, droplet spread) Airborne Common-vehicle spread Host
Goals Microbiology of Healthcare-associated Infections William A. Rutala, Ph.D., M.P.H. Director, Statewide Program for Infection Control and Epidemiology and Research Professor of Medicine, University
More informationPros and Cons of Alternative Diagnostic Testing Strategies for C. difficile Infection
Pros and Cons of Alternative Diagnostic Testing Strategies for C. difficile Infection Christopher R. Polage, MD, MAS Associate Professor of Pathology and Infectious Diseases UC Davis Disclosures Test materials
More informationRapid-VIDITEST C. difficile Ag (GDH) Card/Blister
Li StarFish S.r.l. Via Cavour, 35-20063 Cernusco S/N (MI), Italy Tel. +39-02-92150794 - Fax. +39-02-92157285 info@listarfish.it -www.listarfish.it Rapid-VIDITEST C. difficile Ag (GDH) Card/Blister One
More informationThe incubation period is unknown. However; the onset of clinical disease is typically 5-10 days after initiation of antimicrobial treatment.
C. DIFFICILE Case definition CONFIRMED CASE A patient is defined as a case if they are one year of age or older AND have one of the following requirements: A laboratory confirmation of a positive toxin
More informationABSTRACT PURPOSE METHODS
ABSTRACT PURPOSE The purpose of this study was to characterize the CDI population at this institution according to known risk factors and to examine the effect of appropriate evidence-based treatment selection
More informationClostridium difficile Asymptomatic Carriers The Hidden Part of the Iceberg?
Clostridium difficile Asymptomatic Carriers The Hidden Part of the Iceberg? Disclosures Merck Canada, BD Diagnostics, AMD Medical, Canadian Institute for Health Research Merck Canada, Pfizer OBJECTIVES
More informationCase Studies, or Verification Vignettes
Case Studies, or Verification Vignettes 1 Vignette #1 Change from One Automated AST to Another Your lab is changing from one FDA-cleared automated AST to another Is a verification study required? 2 Yes
More informationGUIDELINE FOR THE MANAGEMENT OF ANTIBIOTIC- ASSOCIATED DIARRHOEA IN ADULTS
GUIDELINE FOR THE MANAGEMENT OF ANTIBIOTIC- ASSOCIATED DIARRHOEA IN ADULTS Version 3.0 Date ratified May 2008 Review date May 2010 Ratified by NUH Antibiotic Guidelines Committee NUH Drugs and Therapeutics
More informationClostridium difficile Testing Algorithms Using Glutamate Dehydrogenase Antigen and C.
JCM Accepts, published online ahead of print on 18 January 2012 J. Clin. Microbiol. doi:10.1128/jcm.05620-11 Copyright 2012, American Society for Microbiology. All Rights Reserved. 1 2 3 Clostridium difficile
More information3/23/2012. Impact of Laboratory Testing on Detection and Treatment of Healthcare Associated Infection: The Case of CDI
Impact of Laboratory Testing on Detection and Treatment of Healthcare Associated Infection: The Case of CDI L. Clifford McDonald, MD Lance R. Peterson, MD March 27, 2012 1 Potential COI L. Clifford McDonald,
More informationDear Healthcare Provider, The information contained here may be very important to your practice. Please take a moment to review this document.
February 2018 Dear Healthcare Provider, The information contained here may be very important to your practice. Please take a moment to review this document. TEST BULLETIN CHLAMYDIA/GONORRHEA SPECIMEN COLLECTION
More informationClostridium difficile Infection (CDI)
18.09.10 월요집담회 Clostridium difficile Infection (CDI) R4 송주혜 Clostridium difficile infection (CDI) Anaerobic gram (+), spore-forming, toxin(tcda&tcdb)-producing bacillus Transmitted among humans through
More informationClostridium Difficile Associated Disease. Edmund Krasinski, Jr., D.O., F.A.C.G. Southwest Conference on Medicine 2011
Clostridium Difficile Associated Disease Edmund Krasinski, Jr., D.O., F.A.C.G. Southwest Conference on Medicine 2011 Introduction Which of the following is more common in community hospitals in the Southeast
More informationINTERPATH LABORATORY, INC. TEST UPDATES
EFFECTIVE DATE: January 25, 2016 INTERPATH LABORATORY, INC. TEST UPDATES Please take note of the following test updates and make the appropriate changes in your Interpath Service Manual. Feel free to contact
More informationHIMSS Davies Enterprise Award Submission
HIMSS Davies Enterprise Award Submission Applicant Organization: St. Clair Hospital Organization s Address: 1000 Bower Hill Road, Pittsburgh, PA, 15243 Submitter s Name: Richard J. Schaeffer Submitter
More informationNHSN Tips for CMS Hospital IQR Program: MRSA Bacteremia and CDI LabID Healthcare Personnel Influenza Vaccination
NHSN Tips for CMS Hospital IQR Program: MRSA Bacteremia and CDI LabID Healthcare Personnel Influenza Vaccination Maggie Dudeck, MPH, CPH Epidemiologist National Provider Education Webcast May 1, 2013 National
More informationAn Oral Fecal Transplant for Lunch?- Frankly Speaking EP 53
An Oral Fecal Transplant for Lunch?- Frankly Speaking EP 53 Transcript Details This is a transcript of an episode from the podcast series Frankly Speaking accessible at Pri- Med.com. Additional media formats
More informationDoes Empirical Clostridium difficile Infection (CDI) Therapy Result in False-Negative CDI Diagnostic Test Results?
MAJOR ARTICLE Does Empirical Clostridium difficile Infection (CDI) Therapy Result in False-Negative CDI Diagnostic Test Results? Venkata C. K. Sunkesula, 1 Sirisha Kundrapu, 1 Christine Muganda, 3 Ajay
More informationClostridium difficile (C. difficile) and Staphylococcus aureus bacteraemia (MRSA and MSSA) Bi-annual Report. Surveillance: Report:
Surveillance: Report: Clostridium difficile (C. difficile) and Staphylococcus aureus ( and ) Bi-annual Report Time period: 1 st April to 30 th September 2016 Health Board: Wales Content: Issued by: Pg
More informationCDI The Impact. Disclosures. Acknowledgments. Objectives and Agenda. What s in the Name? 11/14/2012. Lets Talk Numbers
Disclosures No conflict of interest to declare Acknowledgments Objectives and Agenda Society for Healthcare Epidemiology of America (SHEA) and the Infectious Diseases Society of America (IDSA) Guidelines
More informationDISCLOSURE Relevant relationships with commercial entities Wyeth (received advisory board & speaker honoraria) Potential for conflicts of interest wit
GASTROENTERITIS DISCLOSURE Relevant relationships with commercial entities Wyeth (received advisory board & speaker honoraria) Potential for conflicts of interest within this presentation fidaxomicin (which
More informationEVALUATION OF THE COBAS LIAT (ROCHE ) AND THE LIAISON MDX (DIASORIN )
EVALUATION OF THE COBAS LIAT (ROCHE ) AND THE LIAISON MDX (DIASORIN ) Delefortrie Quentin Intern in Clinical Pathology Corata, 20-21 September 2018 Presentation Plan Evaluation of the cobas Liat Influenza
More informationClostridioides difficile Infection: What s the BIG Stink?
Clostridioides difficile Infection: What s the BIG Stink? GLORIA MATHIS, RN, BSN, CIC 29 TH ANNUAL MEDICAL SURGICAL CONFERENCE APRIL 4, 2019 SAN FRANCISCO, CA I am sre my patient has C. diff. I cold smell
More information"QUIK CHEK"[tw])) NOT ((therapy[ti] OR treatment[ti] OR treat*[ti]) NOT (diagnosis[ti] OR
Supporting information Appendix 1: Search strategy Pubmed (("Clostridium Infections/diagnosis"[majr] AND "Clostridium difficile"[majr]) OR (((("Clostridium difficile"[majr] OR "Clostridium Difficile"[ti])
More informationLeveraging Technology to Prevent Catheter- Associated Urinary Tract Infections (CAUTI): Disrupting the Lifecycle of the Urinary Catheter
Leveraging Technology to Prevent Catheter- Associated Urinary Tract Infections (CAUTI): Disrupting the Lifecycle of the Urinary Catheter Zachary N Gordon, MD ABMS Annual Conference September 28, 2016 CAUTIs:
More informationLifting the lid on a difficile problem part 2 (Clinical) Evidence Based Practice. Problem in evolution (1) Problem in evolution (1) Interventions (2)
Lifting the lid on a difficile problem part (Clinical) Dr Philip T Mannion Consultant Microbiologist, Rhyl Evidence Based Practice Antibiotic prescribing guidance Isolation policy Hand hygiene (soap and
More informationDEPARTMENT OF MICROBIOLOGY IMPORTANT NOTICE TO USERS Turnaround Times (TATs) for Microbiology Investigations
Dear User, ISSUE: M008 DEPARTMENT OF MICROBIOLOGY IMPORTANT NOTICE TO USERS Turnaround Times (TATs) for Microbiology Investigations In order to comply with national quality guidance and as part of our
More informationNew diagnostic tests for sexually transmitted infections. Jens Van Praet 30/11/2018
New diagnostic tests for sexually transmitted infections Jens Van Praet 30/11/2018 Introduction Data from our national microbiological labs suggest STIs are an important clinical issue Correlation with
More informationGetting to Know You. Tackling Clostridium difficile in Nursing Homes. Outline. C. difficile Epidemiology 11/18/2013
Tackling Clostridium difficile in Nursing Homes Getting to Know You Emily Lutterloh, MD, MPH Director, Bureau of Healthcare Associated Infections New York State Department of Health Outline Getting to
More information2018 CNISP HAI Surveillance Case definitions
2018 CNISP HAI Surveillance Case definitions The following case definitions for the surveillance of healthcare-associated infections (HAIs) are used by all acute-care hospitals that participate in the
More informationClostridium difficile Infection (CDI) Guideline
Clostridium difficile Infection (CDI) Guideline Site Applicability All VCH PHC acute care and residential sites. Practice Level Physicians basic skill Pharmacists basic skill Nurses (RN, LPN, RPN) basic
More informationCanadian Nosocomial Infection Surveillance Program
Canadian Nosocomial Infection Surveillance Program 2015-2017 Surveillance for Clostridium difficile infection (CDI) Dec 23, 2016 Working Group: Kevin Katz (Chair), Andy Simor, Geoff Taylor, Charles Frenette,
More informationClostridium Difficile Infection in Adults Treatment and Prevention
Clostridium Difficile Infection in Adults Treatment and Prevention Definition: Clostridium Difficile colonizes the human intestinal tract after the normal gut flora has been altered by antibiotic therapy
More informationC. DIFFICILE UPDATE. Heather Bell, DO Infectious Diseases Physician
C. DIFFICILE UPDATE Heather Bell, DO Infectious Diseases Physician None to report DISCLOSURE Case review Review IDSA CDI guidelines discuss changes Questions Testing recommendations Treatment recommendations
More informationFollow this and additional works at:
Regis University epublications at Regis University Celebration of Scholarship and Research Center for Scholarship and Research Engagement Spring -11-17 Implementation of education with ongoing feedback
More informationBezlotoxumab (Zinplava) as Adjunct Treatment for Clostridium difficile. Janel Liane Cala, RPh Medical Center Hospital
Bezlotoxumab (Zinplava) as Adjunct Treatment for Clostridium difficile Janel Liane Cala, RPh Medical Center Hospital Objectives Review pathophysiology, risk factors, prevention, and treatment options of
More informationIHI Expedition Reducing Clostridium difficile Infections Session 2: Rapid Detection and Isolation
July 9, 2014 These presenters have nothing to disclose IHI Expedition Reducing Clostridium difficile Infections Session 2: Rapid Detection and Isolation Brian Koll, MD Cliff McDonald, MD Diane Jacobsen
More informationYour Friendly Neighborhood Hospital Epidemiologist: Role, Responsibility, and Relationships. Jason Bowling, M.D. UT Health San Antonio
Your Friendly Neighborhood Hospital Epidemiologist: Role, Responsibility, and Relationships Jason Bowling, M.D. UT Health San Antonio Objectives Review the skills and competencies of an effective hospital
More informationGuidelines on the Prevention, Detection, And Management of Clostridium difficile Infection
Guidelines on the Prevention, Detection, And Management of Clostridium difficile Infection 1 CLINICAL GUIDELINES CHECKLIST Name of guidelines Guidelines on the Prevention, Detection, and Management of
More informationGuidance on the use of molecular testing for Neisseria gonorrhoeae in Diagnostic Laboratories 2011
Guidance on the use of molecular testing for Neisseria gonorrhoeae in Diagnostic Laboratories 2011 Molecular testing for gonorrhoea working group (see Appendix) Prepared by Kirstine Eastick March 2012-1
More informationComparison of Clinical Features Between Inpatient and Outpatient Cases of Clostridium difficile Infection
Comparison of Clinical Features Between Inpatient and Outpatient Cases of Clostridium difficile Infection Marcus J. Belger A thesis submitted in partial fulfillment of the requirements for the degree of
More informationSpecimen Collection and Source Mapping
Specimen Collection and Source Mapping October 4, 2016 Steve Renfroe MT(ASCP) Consultant, Clinical Specialty What is Your Culture? Does your urinalysis reflex to culture? Does Lab educate your Nursing
More information